← Back to All US Stocks

CLS Stock Analysis - CELESTICA INC AI Rating

CLS NYSE Printed Circuit Boards A6 CIK: 0001030894
Recently Updated • Analysis: Mar 22, 2026 • SEC Data: 2025-12-31
AI Rating
STRONG BUY
82% Confidence

📊 CLS Key Takeaways

Revenue: $12.4B
Net Margin: 6.7%
Free Cash Flow: $458.3M
Current Ratio: 1.44x
Debt/Equity: 0.34x
EPS: $7.16
AI Rating: STRONG BUY with 82% confidence

Investment Thesis

Celestica demonstrates exceptional operational execution with 28.5% revenue growth and net income nearly doubling YoY, driven by strong margin expansion and robust free cash flow generation. The company maintains healthy balance sheet metrics with moderate leverage (0.34x D/E) and solid liquidity, supported by 659.5M in operating cash flow and 458.3M in free cash flow, indicating sustainable growth trajectory.

CLS Strengths

  • + Exceptional net income growth of 94.5% YoY significantly outpacing 28.5% revenue growth demonstrates operating leverage and margin expansion
  • + Strong free cash flow generation of 458.3M with 3.7% FCF margin provides capital flexibility for debt reduction, investments, or shareholder returns
  • + Outstanding returns on equity (37.6%) and assets (11.5%) indicate highly efficient capital deployment and operational excellence
  • + Moderate leverage at 0.34x D/E ratio with 750.5M long-term debt provides balance sheet strength and refinancing flexibility
  • + Significant insider activity with 33 Form 4 filings in last 90 days suggests management confidence in business trajectory

CLS Risks

  • ! Quick ratio of 0.88x indicates potential near-term liquidity constraints despite adequate current ratio, requiring monitoring of working capital management
  • ! Operating margin of 8.4% and net margin of 6.7% remain compressed relative to profitability growth, suggesting pricing power or operational efficiency may be at limits
  • ! Revenue concentration in printed circuit boards sector (SIC 3672) exposes company to cyclical semiconductor and electronics manufacturing demand
  • ! Missing interest coverage ratio data prevents full assessment of debt service capacity, particularly important given 750.5M long-term debt load
  • ! Gross margin of only 12.1% is thin and vulnerable to input cost inflation, supply chain disruptions, or competitive pricing pressures

Key Metrics to Watch

CLS Financial Metrics

Revenue
$12.4B
Net Income
$832.5M
EPS (Diluted)
$7.16
Free Cash Flow
$458.3M
Total Assets
$7.2B
Cash Position
$595.6M

💡 AI Analyst Insight

The relatively thin 3.7% FCF margin may limit capital allocation flexibility.

CLS Profitability Ratios

Gross Margin 12.1%
Operating Margin 8.4%
Net Margin 6.7%
ROE 37.6%
ROA 11.5%
FCF Margin 3.7%

CLS vs Default Sector

How CELESTICA INC compares to Default sector averages

Net Margin
CLS 6.7%
vs
Sector Avg 12.0%
CLS Sector
ROE
CLS 37.6%
vs
Sector Avg 15.0%
CLS Sector
Current Ratio
CLS 1.4x
vs
Sector Avg 1.8x
CLS Sector
Debt/Equity
CLS 0.3x
vs
Sector Avg 0.7x
CLS Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

CLS Balance Sheet & Liquidity

Current Ratio
1.44x
Quick Ratio
0.88x
Debt/Equity
0.34x
Debt/Assets
69.3%
Interest Coverage
N/A
Long-term Debt
$750.5M

CLS 5-Year Financial Trend

CLS 5-year financial data: Year 2024: Revenue $9.6B, Net Income $180.1M, EPS $1.46. Year 2025: Revenue $12.4B, Net Income $244.4M, EPS $2.03.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: CELESTICA INC's revenue has grown significantly by 28% over the 5-year period, indicating strong business expansion. The most recent EPS of $2.03 reflects profitable operations.

CLS Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
3.7%
Free cash flow / Revenue

CLS Quarterly Performance

Quarterly financial performance data for CELESTICA INC including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $2.5B $89.5M $0.75
Q2 2025 $2.4B $95.0M $0.80
Q1 2025 $2.2B $86.2M $0.74

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

CLS Capital Allocation

Operating Cash Flow
$659.5M
Cash generated from operations
Stock Buybacks
$153.4M
Shares repurchased (TTM)
Capital Expenditures
$201.2M
Investment in assets
Dividends
None
No dividend program

CLS SEC Filings

Access official SEC EDGAR filings for CELESTICA INC (CIK: 0001030894)

📋 Recent SEC Filings

Date Form Document Action
Feb 27, 2026 10-K cls-20251231.htm View →
Feb 9, 2026 4 xslF345X05/ownership.xml View →
Feb 6, 2026 4 xslF345X05/ownership.xml View →
Feb 6, 2026 4 xslF345X05/ownership.xml View →
Feb 6, 2026 4 xslF345X05/ownership.xml View →

Frequently Asked Questions about CLS

What is the AI rating for CLS?

CELESTICA INC (CLS) has an AI rating of STRONG BUY with 82% confidence, based on fundamental analysis of SEC EDGAR filings.

What are CLS's key strengths?

Exceptional net income growth of 94.5% YoY significantly outpacing 28.5% revenue growth demonstrates operating leverage and margin expansion. Strong free cash flow generation of 458.3M with 3.7% FCF margin provides capital flexibility for debt reduction, investments, or shareholder returns.

What are the risks of investing in CLS?

Quick ratio of 0.88x indicates potential near-term liquidity constraints despite adequate current ratio, requiring monitoring of working capital management. Operating margin of 8.4% and net margin of 6.7% remain compressed relative to profitability growth, suggesting pricing power or operational efficiency may be at limits.

What is CLS's revenue and growth?

CELESTICA INC reported revenue of $12.4B.

Does CLS pay dividends?

CELESTICA INC does not currently pay dividends.

Where can I find CLS SEC filings?

Official SEC filings for CELESTICA INC (CIK: 0001030894) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is CLS's EPS?

CELESTICA INC has a diluted EPS of $7.16.

How is the AI analysis conducted?

Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.

Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 22, 2026 | Data as of: 2025-12-31 | Powered by Claude AI